(NASDAQ: KOD) Kodiak Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 27.06%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41.04%.
Kodiak Sciences's earnings in 2025 is -$199,825,000.On average, 8 Wall Street analysts forecast KOD's earnings for 2025 to be -$218,697,639, with the lowest KOD earnings forecast at -$223,108,250, and the highest KOD earnings forecast at -$209,094,656. On average, 8 Wall Street analysts forecast KOD's earnings for 2026 to be -$186,280,968, with the lowest KOD earnings forecast at -$237,602,521, and the highest KOD earnings forecast at -$92,068,204.
In 2027, KOD is forecast to generate -$172,959,338 in earnings, with the lowest earnings forecast at -$247,955,573 and the highest earnings forecast at -$64,336,817.